InvestorsHub Logo

HadToHavit

01/10/22 10:14 PM

#343713 RE: BIOChecker4 #343712

……. And how many COVID vax and therapies are available in 24 months…..
I started investing in a Anavax in 2014. They go back further. Just sayin
Their copyright is 2007. We talking 15 years ?
Go to the website. Look at the talent…. The education and experience of these people. None of them would subscribe to investing their reputations on a dud. NONE.
I’m 66. Sticking with them. Elon has a big chunk of me too. For a long time.
I believed in him too. Still do. He has alien bloodline you know ??

Pazzo1212

01/10/22 10:28 PM

#343715 RE: BIOChecker4 #343712

Missling has former FDA employees on the payroll. My guess is collectively they know a hell of lot more than you. I’ll take their guidance over some stock board junkie anytime.

Bourbon_on_my_cornflakes

01/10/22 10:28 PM

#343716 RE: BIOChecker4 #343712

FORGOT THE COLON - This is not how drug development works: "It’s going to take many years and tens of millions of dollars or more to get an answer, if ever."

That's correct, that is not how it works. WE will get answers, and soon. And it won't take $10s of millions.

273 and 371 do not have to be developed. They are already here, so no cost for that. P1s are already done, so no more money or time for that. P2s are done for 273, so no more money or time for that. P3s for 273 are months away from completion so little money and time left needed for that.

The numbers you are quoting are starting from zero, not employing the lastest genomic and AI tech. We are on 3rd base getting ready to score.

Fact is Dr. M has us set up for potential approvals in 2022 or 2023 at the latest.

CommonCents3

01/10/22 10:50 PM

#343718 RE: BIOChecker4 #343712

This line of thinking would’ve been true pre-COVID vaccine. W/ social media there will far too much pressure in the FDA to approve this drug IF it actually works. The risk here isn’t whether or not Missling can navigate the waters here, it’s whether or not this drug is what we think it is.

GLTA

CC3